Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01900366 · ClinicalTrials.gov registry record
Pilot Study for Noninvasive Spectroscopic Detection of Adipose Tissue Inflammation in Obesity
A clinical trial, sponsored by Rockefeller University.
- Completed
- Registry status
- 14
- Enrollment target
NCT01900366: Completed study, sponsored by Rockefeller University.
NCT01900366 is a clinical trial that has completed, run by Rockefeller University. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01900366 has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
This study will test the potential of two techniques using light properties of adipose tissue to diagnose crown-like structures and inflammation to be compared with pathologic examination of adipose tissue biopsies from ongoing clinical studies.
Primary Outcome
Classification of adipose tissue as healthy or inflamed by Raman Spectroscopy
Interventions
- PROCEDURE Fat Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-08 |
| Est. Completion | 2016-08 |
What the finished NCT01900366 record still lists
NCT01900366 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Fat Biopsy is the first listed.
NCT01900366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01900366 about?
NCT01900366 is a clinical study titled "Pilot Study for Noninvasive Spectroscopic Detection of Adipose Tissue Inflammation in Obesity". This study will test the potential of two techniques using light properties of adipose tissue to diagnose crown-like structures and inflammation to be compared with pathologic examination of adipose tissue biopsies from ongoing clinical studies.
What is the current status of trial NCT01900366?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2013-08. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01900366?
The interventions under investigation include: Fat Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01900366?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia